Pfizer Inc (MIL:1PFE)
€ 24.625 -0.16 (-0.65%) Market Cap: 138.78 Bil Enterprise Value: 192.52 Bil PE Ratio: 34.89 PB Ratio: 1.59 GF Score: 64/100

Pfizer Inc at Truist Securities Life Sciences Summit (May Series) Transcript

May 05, 2021 / 05:50PM GMT
Gregory B. Gilbert
Truist Securities, Inc., Research Division - Analyst

Hello, everyone. I'm Gregg Gilbert. I cover pharmaceuticals here at Truist. I'm fortunate to be hosting this next fireside, next to Chuck's fireplace with Pfizer.

Before we begin, I need to read the following disclaimer. This call is arranged by Truist Securities Research, released by institutional investors and issuer clients, as defined by FINRA. If you are not an institutional investor or issuer, please disconnect at this time. For required disclosures, please see our website at truistsecurities.com or our equity research library.

For this next fireside, we have with us Chuck Triano, who's Pfizer's Senior Vice President and Head of IR. Chuck, thank you for joining me, and thanks to our Truist investor clients that are following along now or later.

Questions & Answers

Gregory B. Gilbert
Truist Securities, Inc., Research Division - Analyst

So Chuck, I can't believe it was over 20 years ago when we met. You were new to in-house IR, and I was new to covering

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot